Pancreatic Cancer Research

ResearcherCalifornia NanoSystems InstituteActive in the last 2 years

Jeffrey I Zink

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9792-4976; OpenAlex author ID A5045784662; NIH RePORTER profile ID 8820471. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
2
Labs led
0
Collaborators
3
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 grant · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant

Papers 1

  1. Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. Co-author DOI 10.1021/nn404083m↗

Grants 2

  1. Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy R01CA247666↗
  2. UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer U01CA198846↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. André E. Nel · 1 shared paper, 2 shared grants, 2013–2024 · strength 1.22
  2. Huan Meng · 1 shared paper, 1 shared grant, 2013–2019 · strength 0.31
  3. Timothy R. Donahue · 1 shared grant, 2019 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.